Investors.guardanthealth.com

Guardant Health, Inc.

WEBInvestor Relations. Guardant Health is a leading precision oncology company focused on helping conquer cancer through our proprietary blood tests, vast data sets, and …

Actived: 4 days ago

URL: https://investors.guardanthealth.com/home/default.aspx

Guardant Health Reports First Quarter 2024 Financial Results and

WEBRevenue growth of 31% driven by strong clinical and biopharma volume and Guardant360 ASP tailwinds Guardant Health, Inc. (Nasdaq: GH), a leading precision …

Category:  Health Go Health

Guardant Health Reports Fourth Quarter and Full Year 2022 …

WEBQ4 clinical and biopharma volumes up 41% and 24% year over year Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company focused on …

Category:  Health Go Health

Guardant Health Reports Fourth Quarter and Full Year 2023 …

WEBFull year 2023 revenue growth of 25% driven by clinical volume growth of 39% Expects full year 2024 revenue to be in the range of $655 to $670 million Guardant …

Category:  Health Go Health

Guardant Health, Inc.

WEBGuardant Health plans to report its fourth quarter and full year audited financial results for the period ended December 31, 2023, during its February 2024 …

Category:  Health Go Health

Guardant Health Reports Third Quarter 2023 Financial Results and

WEBQ3 revenue increased 22% year over year driven by clinical volume growth of 35% Raises 2023 revenue guidance to $553 to 556 million Guardant Health, Inc. …

Category:  Health Go Health

Guardant Health, Inc.

WEB- The test demonstrated 83% sensitivity for the detection of colorectal cancer with specificity of 90% - Results pave the way for first potential FDA-approved and …

Category:  Cancer Go Health

Guardant Health Reports Third Quarter 2022 Financial Results

WEBQ3 clinical and biopharma volumes up 42% and 40% year over year Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company focused on …

Category:  Health Go Health

Guardant Health, Inc.

WEBFull year clinical and biopharma volumes up 42% and 40% year over year Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company focused on …

Category:  Health Go Health

Guardant Health Reports First Quarter 2021 Financial Results

WEBAchieved revenue of $78.7 million, driven by approximately 18,400 clinical tests Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company …

Category:  Health Go Health

Guardant Health, Inc.

WEBGuardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced it will report financial results for the third quarter 2022 after market …

Category:  Health Go Health

Guardant Health, Inc.

WEBAbout Guardant Health. Guardant Health is a leading precision medicine company focused on guarding wellness and giving every person more time free from …

Category:  Medicine Go Health

Guardant Health Expands Guardant360® Portfolio With New Tests …

WEBGuardant Health has commercially launched liquid biopsy-based Guardant360 ®, Guardant360 CDx, Guardant360 TissueNext™, Guardant360 …

Category:  Health Go Health

Guardant Health, Inc.

WEBAt Guardant Health Inc., we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you …

Category:  Health Go Health

Guardant Health, Inc.

WEBPresentations to highlight role of liquid biopsy tests and real-world data to identify biomarkers, predict patient response to therapy, and detect resistance …

Category:  Health Go Health

Guardant Health, Inc.

WEBGuardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that it has entered into a common stock purchase agreement with …

Category:  Health Go Health

Guardant Health Reports Third Quarter 2021 Financial Results

WEB2021 Guidance. Guardant Health expects full year 2021 revenue to be in the range of $360 million to $370 million, representing 26% to 29% growth over full year …

Category:  Health Go Health

Guardant Health, Inc.

WEBHighly sensitive Shield test offers convenient screening method that can be completed with simple blood draw, helping overcome barriers to compliance Test …

Category:  Health Go Health

Guardant Health, Inc.

WEBAbout Guardant Health. Guardant Health is a leading precision medicine company focused on guarding wellness and giving every person more time free from …

Category:  Medicine Go Health

Guardant Health to Appeal Federal District Court Verdict

WEBGuardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced it intends to appeal yesterday’s verdict in the U.S. District Court for the …

Category:  Health Go Health

Guardant Health Completes Purchase of Guardant Health AMEA …

WEBGuardant Health, Inc. (NASDAQ:GH), a leading precision oncology company, today announced it has purchased the remaining shares of Guardant Health …

Category:  Health Go Health

Guardant Health to Host Investor Day on September 7, 2023

WEBGuardant Health, Inc. (Nasdaq: GH), a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary tests, vast …

Category:  Cancer Go Health